Xiyan Mai

Molecular Innovations (United States)

Papers

1

Total Citations

39

H-Index

1

About

Xiyan Mai is a leading innovator in the field of bioanalytical engineering, with a primary focus on developing automated, high-throughput immunoassay platforms. Their most significant contribution is the pioneering work on "Sample-to-Answer Robotic ELISA," a breakthrough that directly addresses the longstanding limitations of conventional enzyme-linked immunosorbent assays. By integrating robotics with microfluidics, Mai has dramatically reduced the labor, instrument footprint, and operation time traditionally required for these critical diagnostic tests. This seminal paper, published in 2021, has already garnered 39 citations, reflecting its rapid adoption and influence within the lab-on-a-chip and point-of-care diagnostics communities. Mai’s research is fundamentally reshaping how immunoassays are performed, moving them from cumbersome, centralized lab procedures toward streamlined, automated systems. This work not only enhances reproducibility but also holds immense potential for accelerating clinical diagnostics and field-deployable health monitoring, establishing Mai as a key figure in the next generation of automated biomedical analysis.

Research Focus

Key Achievements

1
H-Index
1
Papers
39
Total Citations
39
Avg Citations/Paper
🏆 Most Cited Paper
Sample-to-Answer Robotic ELISA
39 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Molecular Innovations (United States)

Top Papers

  1. 1
    Sample-to-Answer Robotic ELISA
    39 citations · 2021

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago